Defects in optineurin- and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis

被引:78
|
作者
Sundaramoorthy, Vinod [1 ,2 ]
Walker, Adam K. [2 ]
Tan, Vanessa [1 ]
Fifita, Jennifer A. [1 ]
Mccann, Emily P. [1 ]
Williams, Kelly L. [1 ]
Blair, Ian P. [1 ]
Guillemin, Gilles J. [1 ]
Farg, Manal A. [2 ]
Atkin, Julie D. [1 ,2 ]
机构
[1] Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, N Ryde, NSW 2109, Australia
[2] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Bundoora, Vic 3086, Australia
基金
英国医学研究理事会;
关键词
ENDOPLASMIC-RETICULUM STRESS; PROTEIN-DISULFIDE-ISOMERASE; CORD MOTOR-NEURONS; MOUSE MODEL; GOLGI-APPARATUS; AUTOPHAGOSOME MATURATION; MUTATIONS; FRAGMENTATION; PATHOLOGY; RECEPTOR;
D O I
10.1093/hmg/ddv126
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder primarily affecting motor neurons. Mutations in optineurin cause a small proportion of familial ALS cases, and wild-type (WT) optineurin is misfolded and forms inclusions in sporadic ALS patient motor neurons. However, it is unknown how optineurin mutation or misfolding leads to ALS. Optineurin acts an adaptor protein connecting the molecular motor myosin VI to secretory vesicles and autophagosomes. Here, we demonstrate that ALS-linked mutations p.Q398X and p.E478G disrupt the association of optineurin with myosin VI, leading to an abnormal diffuse cytoplasmic distribution, inhibition of secretory protein trafficking, endoplasmic reticulum (ER) stress and Golgi fragmentation in motor neuron-like NSC-34 cells. We also provide further insight into the role of optineurin as an autophagy receptor. WT optineurin associated with lysosomes and promoted autophagosome fusion to lysosomes in neuronal cells, implying that it mediates trafficking of lysosomes during autophagy in association with myosin VI. However, either expression of ALS mutant optineurin or small interfering RNA-mediated knockdown of endogenous optineurin blocked lysosome fusion to autophagosomes, resulting in autophagosome accumulation. Together these results indicate that ALS-linked mutations in optineurin disrupt myosin VI-mediated intracellular trafficking processes. In addition, in control human patient tissues, optineurin displayed its normal vesicular localization, but in sporadic ALS patient tissues, vesicles were present in a significantly decreased proportion of motor neurons. Optineurin binding to myosin VI was also decreased in tissue lysates from sporadic ALS spinal cords. This study therefore links several previously described pathological mechanisms in ALS, including defects in autophagy, fragmentation of the Golgi and induction of ER stress, to disruption of optineurin function. These findings also indicate that optineurin-myosin VI dysfunction is a common feature of both sporadic and familial ALS.
引用
收藏
页码:3830 / 3846
页数:17
相关论文
共 50 条
  • [31] Differential Involvement of Optineurin in Amyotrophic Lateral Sclerosis With or Without SOD1 Mutations
    Deng, Han-Xiang
    Bigio, Eileen H.
    Zhai, Hong
    Fecto, Faisal
    Ajroud, Kaouther
    Shi, Yong
    Yan, Jianhua
    Mishra, Manjari
    Ajroud-Driss, Senda
    Heller, Scott
    Sufit, Robert
    Siddique, Nailah
    Mugnaini, Enrico
    Siddique, Teepu
    ARCHIVES OF NEUROLOGY, 2011, 68 (08) : 1057 - 1061
  • [32] Four novel optineurin mutations in patients with sporadic amyotrophic lateral sclerosis in Mainland China
    Yang, Lu
    Cheng, Yanfei
    Jia, Xinmiao
    Liu, Xudong
    Li, Xiuli
    Zhang, Kang
    Shen, Dongchao
    Liu, Mingsheng
    Guan, Yuzhou
    Liu, Qing
    Cui, Liying
    Li, Xiaoguang
    NEUROBIOLOGY OF AGING, 2021, 97 : 149.e1 - 149.e8
  • [33] Nuclear trafficking in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
    Mihevc, Sonja Prpar
    Darovic, Simona
    Kovanda, Anja
    Cesnik, Ana Bajc
    Zupunski, Vera
    Rogelj, Boris
    BRAIN, 2017, 140 : 13 - 26
  • [34] Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms
    Markovinovic, Andrea
    Cimbro, Raffaello
    Ljutic, Tereza
    Kriz, Jasna
    Rogelj, Boris
    Munitic, Ivana
    PROGRESS IN NEUROBIOLOGY, 2017, 154 : 1 - 20
  • [35] Amyotrophic Lateral Sclerosis, FUS and Protein Synthesis Defects
    Amanda Faria Assoni
    Floris Foijer
    Mayana Zatz
    Stem Cell Reviews and Reports, 2023, 19 : 625 - 638
  • [36] Amyotrophic Lateral Sclerosis, FUS and Protein Synthesis Defects
    Assoni, Amanda Faria
    Foijer, Floris
    Zatz, Mayana
    STEM CELL REVIEWS AND REPORTS, 2023, 19 (03) : 625 - 638
  • [37] The Role of Nucleocytoplasmic Transport Defects in Amyotrophic Lateral Sclerosis
    Vanneste, Joni
    van den Bosch, Ludo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [38] Muscle mitochondrial oxidative defects in amyotrophic lateral sclerosis
    Crugnola, V.
    Lucchini, V.
    Corti, S.
    Addobbati, L.
    Ciammola, A.
    Ticozzi, N.
    Fruguglietti, M. E.
    Prelle, A.
    Santoro, D.
    Virgilio, R.
    Silani, V.
    Bresolin, N.
    Moggio, M.
    Comi, G. P.
    JOURNAL OF NEUROLOGY, 2007, 254 : 183 - 183
  • [39] Concise Review: The Cellular Conspiracy of Amyotrophic Lateral Sclerosis
    Serio, Andrea
    Patani, Rickie
    STEM CELLS, 2018, 36 (03) : 293 - 303
  • [40] Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
    Rizzo, Federica
    Riboldi, Giulietta
    Salani, Sabrina
    Nizzardo, Monica
    Simone, Chiara
    Corti, Stefania
    Hedlund, Eva
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2014, 71 (06) : 999 - 1015